Publication | Open Access

The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression

Tumor BiologyCancer ImmunosurveillanceImmunologyTumor ImmunityColorectal CancerImmune RegulationImmune SurveillanceInhibitory Receptor Cd94/nkg2aT Cell ImmunityHlae/β2m OverexpressionImmune Checkpoint InhibitorCellular Immune ResponseImmune Cell TherapyImmunotherapyMedicineCell BiologyCancer Research